Received Jan 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | X007544 | — |
no reported clinical events; PEDVAX HIB that was administered on 12/8/2025 and had expired on 11/20/2025; This spontaneous report was received from a medical assistant/office manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-Dec-2025, the patient was vaccinated with a dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) (lot #X007544 with valid expiration date reported as 20-Nov-2025) 0.5 mL (rpute of administration and vaccination site were not reported) administered for prophylaxis. Therefore, an expired dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) was administered (expired product administered). The product has not undergone a temperature excursion and there have been no clinical events reported. No additional adverse event (AE)and no product quality complaint (PQC) was noted. No additional information was reported.; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02919063-02919058 , CLIC number : , ESTAR number : , IRMS number : 500TP00000bPyzqYAC|12122025230040|0097 , Central date : 2025-12-15 , Classification : DMC, Attachment description : Call , Safety case number : 2360298 , MNSC case number : 02919063 , MNSC interaction number : 02919058 , Integration log UniqueID : 500TP00000bPyzqYAC|12122025230040|0097 , Service cloud CaseID : 500TP00000bPyzqYAC